Signature Gene Expression Profiles Discriminate between Isoniazid-, Thiolactomycin-, and Triclosan-Treated Mycobacterium tuberculosis

Genomic technologies have the potential to greatly increase the efficiency of the drug development process. As part of our tuberculosis drug discovery program, we used DNA microarray technology to profile drug-induced effects in Mycobacterium tuberculosis. Expression profiles of M. tuberculosis trea...

Description complète

Détails bibliographiques

Publié dans:	Antimicrob Agents Chemother
Auteurs principaux:	Betts, Joanna C., McLaren, Alistair, Lennon, Mark G., Kelly, Fiona M., Lukey, Pauline T., Blakemore, Steve J., Duncan, Ken
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Microbiology (ASM) 2003
Sujets:	Mechanisms of Action: Physiological Effects
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC182614/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12936993/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.9.2903-2913.2003
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!